<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01328288</url>
  </required_header>
  <id_info>
    <org_study_id>HIV-NAT 154</org_study_id>
    <nct_id>NCT01328288</nct_id>
  </id_info>
  <brief_title>Progress Pediatric Study</brief_title>
  <official_title>The Thai Pediatric HIV Disease Progression: An Observational Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The HIV Netherlands Australia Thailand Research Collaboration</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bamrasnaradura Infectious Diseases Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chiangrai Prachanukroh Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanpatong Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The HIV Netherlands Australia Thailand Research Collaboration</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the HIV disease progression in HIV-infected Thai
      children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, observational cohort study. HIV-infected children from 5 institutions
      are followed to assess HIV disease progression: 1. Bamrasnaradura infectious disease
      institute,2. Faculty of Medicine Siriraj Hospital, Mahidol University, 3. Chiangrai
      Prachanukroh Hospital, 4. Sanpatong Hospital and 5. HIV-NAT, Thai Red Cross AIDS Research
      Center.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HIV related adverse events</measure>
    <time_frame>1 year</time_frame>
    <description>time to HIV related adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immunological failure</measure>
    <time_frame>1 year</time_frame>
    <description>time to immunological failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>virological failure</measure>
    <time_frame>1 year</time_frame>
    <description>time to virological failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>time to change of quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>depression</measure>
    <time_frame>1 year</time_frame>
    <description>when patient develops depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>genotypic resistance</measure>
    <time_frame>1 year</time_frame>
    <description>time to genotypic resistance</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">840</enrollment>
  <condition>HIV</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>long-term follow-up of HIV-infected children</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard ART according to the Thai Ministry of Public Health national guidelines</intervention_name>
    <description>Patients may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        long-term follow-up of HIV-infected children from: 1. Bamrasnaradura infectious disease
        institute, 2. Faculty of Medicine Siriraj Hospital, Mahidol University, 3. Chiangrai
        Prachanukroh Hospital, Chiang Rai, 4. Sanpatong Hospital, Chiang Mai, and 5. HIV-NAT, Thai
        Red Cross AIDS Research Center, Bangkok
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age &lt; 18 years old

          2. Have confirmed HIV infection (ELISA,HIV-DNA PCR,HIV-RNA PCR)

          3. Signed consent form

        Exclusion Criteria:

          1. Hospitalization

          2. Emergency case

          3. Incomplete Medical Record
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wisit Prasithsirikul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bamrasnaradura infectious disease institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rawiwan Hansudewechakul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chiangrai Prachanukroh Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wirat Klinbuayam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanpatong Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jintanat Ananworanich, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HIV-NAT, Thai Red Cross - AIDS Research Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kulkanya Chokephaibulkit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanpatong Hospital</name>
      <address>
        <city>Sanpathong</city>
        <state>Chiang Mai</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HIV-NAT, Thai Red Cross AIDS Research Centre</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiangrai Prachanukroh Hospital</name>
      <address>
        <city>Chiang Rai</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bamrasnaradura infectious disease institute</name>
      <address>
        <city>Nonthaburi</city>
        <zip>11000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <link>
    <url>http://www.hivnat.org</url>
    <description>HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)</description>
  </link>
  <results_reference>
    <citation>Bunupuradah T, Sricharoenchai S, Hansudewechakul R, Klinbuayaem V, Teeraananchai S, Wittawatmongkol O, Akarathum N, Prasithsirikul W, Ananworanich J; Pediatric PROGRESS Study Team. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents. Pediatr Infect Dis J. 2015 Mar;34(3):e58-62. doi: 10.1097/INF.0000000000000584.</citation>
    <PMID>25478649</PMID>
  </results_reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2011</study_first_submitted>
  <study_first_submitted_qc>April 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2011</study_first_posted>
  <last_update_submitted>February 19, 2016</last_update_submitted>
  <last_update_submitted_qc>February 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV related adverse events</keyword>
  <keyword>Immunological failure</keyword>
  <keyword>virological failure</keyword>
  <keyword>quality of life</keyword>
  <keyword>depression</keyword>
  <keyword>genotypic resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

